AAPS OpenOrally disintegrating tablets (ODTs) are a solid oral dosage form designed to rapidly disintegrate in the mouth without the need for water, improving patient compliance—particularly among pediatric, geriatric, and dysphagic populations.
Shapali Bagde +3 more
doaj +1 more source
Generic Scrip Share and the Price of Brand-Name Drugs: The Role of the Consumer [PDF]
Generic drug utilization has risen dramatically, from 19% of scrips in 1984 to 47% in 2001, thus bringing significant direct dollar savings. Generic drug use may also yield indirect savings if it lowers the average price of those brand-name drugs that ...
John A. Rizzo, Richard Zeckhauser
core
Are generic immunosuppressants safe and effective? Clinical experience is reassuring and regulation is strict, now we need definitive evidence [PDF]
, 2015 Increasing use of generic drugs is essential to maintain comprehensive and equitable healthcare, given current pressure on budgets through, for instance, ageing populations.
Baumgärtel, C, Godman, B
core +1 more source
Reference Pricing of Pharmaceuticals [PDF]
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the ...
Ingrid Königbauer +2 more
core
Strategic Under-utilization of Patents and Entry Deterrence: The Case of Pharmaceutical Industry [PDF]
This paper seeks to explain why some pharmaceutical companies are observed to withdraw their products before patents are expired and simultaneously introduce new patented (competing) products.
Dutta, Arijita +2 more
core +1 more source
Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation [PDF]
, 2010 Although brand-name pharmaceutical companies routinely procure patents on their innovative medications, such rights are not self-enforcing. Brand-name firms that wish to enforce their patents against generic competitors must commence litigation in the ...
Thomas, John R.
core +1 more source
Price regulation and generic competition in the pharmaceutical market [PDF]
In March 2003 the Norwegian government implemented yardstick based price regulation schemes on a selection of drugs experiencing generic competition. The retail price cap, termed “index price”, on a drug (chemical substance) was set equal to the average ...
Dalen, Dag Morten +2 more
core
MetabolitesBackground: Despite the well-established liver-protective efficacy of monoammonium glycyrrhizinate (MONO), diammonium glycyrrhizinate (DIAM), and magnesium isoglycyrrhizinate (MAGN), which has been translated into clinical practice, their clinical ...
Yihua Zhang +7 more
doaj +1 more source
Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate: Reforming the Drug Approval Process According to Market Principles [PDF]
This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process.
Corinne Sauer, Robert Sauer
core
Missing After Mensing: A Remedy for Generic Drug Consumers [PDF]
, 2012 The U.S. Supreme Court’s 2011 decision in PLIVA v. Mensing left consumers of generic drugs without a remedy for failure-to-warn claims. The Court held that FDA regulations made it impossible for a generic drug manufacturer unilaterally to enhance its ...
Stoddart, Allison
core